» Articles » PMID: 21940040

Effective Radiation Exposure in Evaluation and Follow-up of Patients with Urolithiasis

Overview
Journal Urology
Specialty Urology
Date 2011 Sep 24
PMID 21940040
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To quantify the effective radiation dose associated with the evaluation and follow-up of patients with urolithiasis.

Methods: Retrospective review was performed for consecutive patients presenting to a tertiary stone clinic with acute stone episodes between November 2007 and December 2008, and had at least 2 years of follow-up. Number and modality of imaging studies were collected. Effective radiation exposure (ERE) doses were calculated from the dose length product values reported with each computed tomography (CT) scan.

Results: There were 72 males and 32 females with a mean age of 49 years (range 21-78). Patients underwent an average 1.8 (range 0-5) and 0.7 (range 0-2) plain radiographs, 0.82 (range 0-4) and 0.15 (range 0-2) CTs, 0.09 (range 0-1) and 0.03 (range 0-1) intravenous urograms, and 0.3 (range 0-1) and 0.6 (range 0-2) ultrasounds (US) during the first and second years, respectively (all P<.05). The average calculated ERE dose per CT scan was 23.16 mSv (range 4.94-72.77). The calculated mean ERE dose per patient significantly decreased from 29.29 mSv (range 1.7-77.27) in the first year to 8.04 mSv (range 1.4-24.72) in the second year (P<.01). This was because of significantly fewer CT scans and significantly more US imaging during the second year (P<.05). Although 18 (17.3%) patients exceeded 50 mSv during the first year, none exceeded this threshold during the second year. The mean ERE dose did not correlate with stone location, patient age, and sex.

Conclusion: The calculated mean ERE dose significantly decreased during the second year of follow-up in patients with urolithiasis because of significantly higher use of US.

Citing Articles

Follow-up of urolithiasis patients after treatment: an algorithm from the EAU Urolithiasis Panel.

Lombardo R, Tzelves L, Geraghty R, Davis N, Neisius A, Petrik A World J Urol. 2024; 42(1):202.

PMID: 38546854 DOI: 10.1007/s00345-024-04872-y.


Application of ultrasound imaging in the treatment of urinary tract stones.

Hamamoto S, Inoue T, Okada S, Taguchi K, Yasui T J Med Ultrason (2001). 2023; .

PMID: 37572224 DOI: 10.1007/s10396-023-01343-6.


Radiation protection measures during endourological therapies.

Tzelves L, Juliebo-Jones P, Manolitsis I, Bellos T, Mykoniatis I, Berdempes M Asian J Urol. 2023; 10(3):215-225.

PMID: 37538154 PMC: 10394289. DOI: 10.1016/j.ajur.2022.12.001.


Potential Markers to Reduce Non-Contrast Computed Tomography Use for Symptomatic Patients with Suspected Ureterolithiasis.

Avda Y, Shpunt I, Modai J, Leibovici D, Berkowitz B, Shilo Y J Pers Med. 2022; 12(8).

PMID: 36013299 PMC: 9410145. DOI: 10.3390/jpm12081350.


Optimal Delivery of Follow-Up Care for the Prevention of Stone Recurrence in Urolithiasis Patients: Improving Outcomes.

Tzelves L, Berdempes M, Mourmouris P, Mitsogiannis I, Skolarikos A Res Rep Urol. 2022; 14:141-148.

PMID: 35469244 PMC: 9034870. DOI: 10.2147/RRU.S277498.